Top Ten Videos to watch

crime scene
Studio Portrait of Two Young Women Back to Back, One With a Tattoo
Mamie Till and Emmett Till
GOP Redistricting Plot To Unseat Rep. Corrine Brown Exposed
Protests Break Out In Charlotte After Police Shooting
'Keep the Vote Alive!' March Commemorates Civil Rights Act
White man shooting
Gun Violence Continues To Plague Chicago, Over 1,000 Shootings For Year To Date
HS Football
Gun Violence Continues To Plague Chicago, Over 1,000 Shootings For Year To Date
Police Line
2016 Republican National Convention
44th NAACP Image Awards - Show
MD Primary
Premiere Of OWN's 'Queen Sugar' - Arrivals
Democratic National Convention
Los Angeles Rams v San Francisco 49ers
Protesters Demonstrate Against Donald Trump's Visit To Flint Michigan
President Obama Speaks On The Economy In Brady Press Briefing Room
Lil Wayne
Construction Continues On The National Museum of African American History To Open In 2016
Preacher Preaching the Gospel
Hillary Clinton Campaigns In Louisville, Kentucky
Miami Dolphins v Seattle Seahawks
Leave a comment


The FDA has just released a report citing clinical study evidence that the naproxen painkiller Aleve has a lower cardiac risk than ibuprofen rivals such as Motrin and Advil.

An advisory committee made up of doctors and medical experts for the government agency said it recommended a new label for pain relievers containing naproxen, stating there is now credible evidence that the drug carries a lower cardiovascular risk than other meds in that category, according to The Wall St. Journal.

The latest discovery stems from several clinical studies that the FDA has reviewed since 2005, when the heart risks of a class of leading painkillers came under public scrutiny. The class of pain relieving drugs that are being reviewed fall under the heading of NSAIDSs or nonsteroidal anti-inflammatory drugs–naproxen (Aleve), ibuprofen (Motrin, Advil) and prescription drug celecoxib (Celebrex).

What makes naproxen stand out from the other pain killing drugs? Clinicians found that naproxen does not cause cardiovascular events that cause heart attacks at over-the-counter and prescription doses. The heart risks associated with ibuprofen drugs will not be problematic, however, if a person is taking a low dose for a couple of days. The latest research on the ibuprofen findings only pertain to “chronic use and at high doses.”

Experts agree that people with existing heart problems would be well advised to consider the new findings and discuss making a switch to naproxen-containing pain medications with their physicians.

Also On News One:
comments – Add Yours